S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BLRX BioLineRx Ltd

0.724

0.02525 (3.61%)

Jun 05 2024 - Closed

Delayed by 15 minutes

New Collaboration Could Revolutionize Treatment of Chronic Spinal Cord Injuries

In January 2023,

To read the full story on AllPennyStocks.com, click here.

BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more BioLineRx Charts.

BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more BioLineRx Charts.

BioLineRx Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 30 May 2024 (7 days ago) • Edgar (US Regulatory)

U.S. Futures Present Mixed Pre-Market Performance, Oil Prices Surge
Tuesday 28 May 2024 (1 week ago) • IH Market News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 28 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 24 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 17 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 6 May 2024 (1 month ago) • Edgar (US Regulatory)

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Wednesday 17 April 2024 (2 months ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 28 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 16 February 2024 (4 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Sunday 7 January 2024 (5 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 29 December 2023 (5 months ago) • Edgar (US Regulatory)

More BioLineRx Ltd News Articles

NLBNPIT1YD66 20991231 45...

North American Cannabis (CE)

Thales DAO Token

Aptus Large Cap Enhanced...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions